Prevalence of COVID-19-like symptoms in Italy and Lombardy, March-April 2020, and their implications on cancer prevention, diagnosis and management.
Journal
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
ISSN: 1473-5709
Titre abrégé: Eur J Cancer Prev
Pays: England
ID NLM: 9300837
Informations de publication
Date de publication:
01 03 2021
01 03 2021
Historique:
pubmed:
28
5
2020
medline:
7
2
2021
entrez:
28
5
2020
Statut:
ppublish
Résumé
Two population-based surveys on coronavirus disease-2019 (Covid-19)-like symptoms were conducted by BVA-Doxa on representative samples of the general population from Italy and its largest region, Lombardy, with over 10 million inhabitants and heavily struck by Covid-19, on 27-30 March and 3-7 April, on a total of 2000 individuals - 353 from Lombardy. Overall, 14.2% of Italians - and 19.6% in Lombardy - reported Covid-19-like symptoms. The estimated prevalence was higher in the young, in smokers, and in Lombardy over the period 20 March to 7 April. Although the influenza season was ended by mid-March, at least part of the symptoms may be not Covid-19 related. Even assuming that only half are, at least 7% of Italians and 10% in Lombardy had been affected by Covid-19. To these, asymptomatic or paucisymptomatic cases have to be added. These estimates are at least one or two orders of magnitude larger than official registered cases. This has major implications for cancer prevention, management and treatment.
Identifiants
pubmed: 32459664
pii: 00008469-202103000-00001
doi: 10.1097/CEJ.0000000000000604
pmc: PMC7314316
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
123-125Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Références
BMJ. 2020 Apr 17;369:m1544
pubmed: 32303501
Lancet. 2020 Apr 11;395(10231):1225-1228
pubmed: 32178769
JAMA Intern Med. 2020 Jul 1;180(7):927-928
pubmed: 32259190
Eur J Cancer. 2020 Jun;132:98-99
pubmed: 32335477
Eur J Cancer Prev. 2020 Sep;29(5):367-381
pubmed: 32740162
N Engl J Med. 2020 Jun 11;382(24):2368-2371
pubmed: 32302076